FDA FDA OPDP Issues Warning Letter to Galt Pharmaceuticals Regarding Insomnia… Thomas Sullivan Oct 15, 2019 0 The US Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) sent a Warning Letter to Galt…
